Qiao Meng M - OmicsDI

Show results for

Unknown (78)
Proteomics (11)
Transcriptomics (1)

Organisms

Alphavirus (5)
Anemia (5)
Archaea (5)
Bacteria (5)
Betaherpesvirinae (5)
Borrelia (5)
Chlamydomonas reinhardtii (5)
Chlorella vulgaris (5)
Clostridium perfringens (5)
Dengue virus (5)
Eukaryota (5)
Hepatitis B virus (5)
Human alphaherpesvirus 1 (5)
Human betaherpesvirus 5 (5)
Influenza A virus (5)
Influenza C virus (5)
Japanese encephalitis virus group (5)
Kamptonema sp. (5)
Listeria monocytogenes (5)
Mammarenavirus (5)
Miscanthus x giganteus (5)
Mycobacterium tuberculosis (5)
Orthoflavivirus (5)
Pseudomonas aeruginosa (5)
Bos taurus (1)
Homo sapiens (1)
Lacticaseibacillus paracasei (1)
Mus (1)
Mus musculus (1)
Rattus rattus (1)

Repository

iProX (5)
pride (5)
biostudies-arrayexpress (1)
MassIVE (1)

Tissue

Lung (2)
Epithelial cell (1)
Venom apparatus (1)

Disease

Disease free (1)

Technology Type

Mass Spectrometry (5)
Shotgun proteomics (4)
Affinity purification coupled with mass spectrometry proteomics (1)
Bottom-up proteomics (1)

Instrument Platform

LTQ Orbitrap Elite (1)
Orbitrap Fusion (1)
Q Exactive (1)
Q Exactive HF (1)

Publication Date

2022 (3)
2025 (2)
2023 (2)
2018 (2)
2014 (1)
2024 (1)
2017 (1)

Study type

RNA-seq of non coding RNA (1)

Release Date

2025 (15)
2023 (15)
2022 (14)
2024 (11)
2014 (5)
2020 (5)
2021 (4)
2026 (2)
2019 (2)
2016 (2)
2015 (2)
2017 (1)
2012 (1)

Lab affiliation

Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030 (2)
Chair of Proteomics and Bioanalytics, Technische Universität München, Germany (1)
Fujian Provincial Key Laboratory of Insect Ecology, Department of Plant Protection, Fujian Agriculture and Forestry University, Fuzhou 350002, Fujian, China (1)
Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China (1)

Previous page
1 / 9
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 9
Next page

Sort by:

Relevance

Page size

Target Landscape of Clinical Kinase Inhibitors

Here, we provide a comprehensive overview of the selectivity profiles of 242 kinase inhibitors currently in clinical trials. We screened available inhibitors against human protein kinases by using the Kinobead technology resulting in a drug matrix identifying the druggable kinome and related protein...

ORGANISM(S): Homo sapiens (Human)

2017-12-01 | PXD005336 | Pride